These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 38344996)

  • 1. Small Molecule-Drug Conjugates Emerge as a New Promising Approach for Cancer Treatment.
    Wang T; Li M; Wei R; Wang X; Lin Z; Chen J; Wu X
    Mol Pharm; 2024 Mar; 21(3):1038-1055. PubMed ID: 38344996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small molecule- and peptide-drug conjugates addressing integrins: A story of targeted cancer treatment.
    Paulus J; Sewald N
    J Pept Sci; 2024 Jul; 30(7):e3561. PubMed ID: 38382900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small Molecule-Drug Conjugates: Opportunities for the Development of Targeted Anticancer Drugs.
    Zhang J; Hu F; Aras O; Chai Y; An F
    ChemMedChem; 2024 Jun; 19(11):e202300720. PubMed ID: 38396351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural-source payloads used in the conjugated drugs architecture for cancer therapy: Recent advances and future directions.
    Li C; Shi K; Zhao S; Liu J; Zhai Q; Hou X; Xu J; Wang X; Liu J; Wu X; Fan W
    Pharmacol Res; 2024 Sep; 207():107341. PubMed ID: 39134188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small molecule-drug conjugates: A novel strategy for cancer-targeted treatment.
    Zhuang C; Guan X; Ma H; Cong H; Zhang W; Miao Z
    Eur J Med Chem; 2019 Feb; 163():883-895. PubMed ID: 30580240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing the Safety and Efficacy of PSMA-Based Small-Molecule Drug Conjugates by Linker Stabilization and Conjugation to Transthyretin Binding Ligand.
    Amin TU; Emara R; Pal A; Aldawod H; Jiang G; Liang D; Haque Tuhin MT; Balgoname A; Patel AD; Alhamadsheh MM
    J Med Chem; 2022 Nov; 65(22):15473-15486. PubMed ID: 36327103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-Drug Conjugates-A Tutorial Review.
    Baah S; Laws M; Rahman KM
    Molecules; 2021 May; 26(10):. PubMed ID: 34063364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Antibody-Drug Conjugates: Future Perspective Towards Solid Tumor Treatment.
    Pramanik D
    Anticancer Agents Med Chem; 2023; 23(6):642-657. PubMed ID: 36321237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody-Drug Conjugates: A promising breakthrough in cancer therapy.
    Parit S; Manchare A; Gholap AD; Mundhe P; Hatvate N; Rojekar S; Patravale V
    Int J Pharm; 2024 Jun; 659():124211. PubMed ID: 38750981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in non-radioactive PSMA-targeted small molecule-drug conjugates in the treatment of prostate cancer.
    Chen M; Cai L; Xiang Y; Zhong L; Shi J
    Bioorg Chem; 2023 Dec; 141():106889. PubMed ID: 37813074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Advances in Targeted Cancer Therapy: Are PDCs the Next Generation of ADCs?
    Zhang B; Wang M; Sun L; Liu J; Yin L; Xia M; Zhang L; Liu X; Cheng Y
    J Med Chem; 2024 Jul; 67(14):11469-11487. PubMed ID: 38980167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive review on the elaboration of payloads derived from natural products for antibody-drug conjugates.
    Lu N; Wu J; Tian M; Zhang S; Li Z; Shi L
    Eur J Med Chem; 2024 Mar; 268():116233. PubMed ID: 38408390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody drug conjugates as targeted cancer therapy: past development, present challenges and future opportunities.
    Maiti R; Patel B; Patel N; Patel M; Patel A; Dhanesha N
    Arch Pharm Res; 2023 May; 46(5):361-388. PubMed ID: 37071273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spotlight on ideal target antigens and resistance in antibody-drug conjugates: Strategies for competitive advancement.
    Jiang M; Li Q; Xu B
    Drug Resist Updat; 2024 Jul; 75():101086. PubMed ID: 38677200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody Drug Conjugates for Cancer Therapy.
    Polakis P
    Pharmacol Rev; 2016 Jan; 68(1):3-19. PubMed ID: 26589413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Design of next generation antibody drug conjugates].
    Zhu GD; Fu YX
    Yao Xue Xue Bao; 2013 Jul; 48(7):1053-70. PubMed ID: 24133971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular vesicles as modifiers of antibody-drug conjugate efficacy.
    Barok M; Puhka M; Yazdi N; Joensuu H
    J Extracell Vesicles; 2021 Feb; 10(4):e12070. PubMed ID: 33613875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-drug conjugates and bispecific antibodies targeting cancers: applications of click chemistry.
    Hong Y; Nam SM; Moon A
    Arch Pharm Res; 2023 Mar; 46(3):131-148. PubMed ID: 36877356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-Calixarene Drug Conjugate: A General Drug Delivery Platform for Tumor-Targeted Therapy.
    Wu X; Yao S; Huang Q; Ying A; Li Q; Cao X; Wang C; Xiao J; Feng N; Zhang Z; Guo D; Liu Y
    ACS Appl Mater Interfaces; 2024 Aug; 16(32):41939-41948. PubMed ID: 39093637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-Drug Conjugates: The New Frontier of Chemotherapy.
    Ponziani S; Di Vittorio G; Pitari G; Cimini AM; Ardini M; Gentile R; Iacobelli S; Sala G; Capone E; Flavell DJ; Ippoliti R; Giansanti F
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32752132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.